Australians Urged to Vaccinate as RSV Cases Surge

Respiratory Syncytial Virus (RSV) cases in Australia are projected to climb to at least 120,000 by the end of winter, surpassing the current case counts for both influenza and Covid-19. According to the Australian Medical Association (AMA) and the Immunisation Foundation of Australia (IFA), more than 83,000 cases have already been confirmed this season, triggering warnings for vulnerable populations to seek medical advice regarding vaccination.

Rising RSV Case Numbers Compared to Flu and Covid-19

Data indicates that RSV is currently exerting a heavier burden on the Australian healthcare system than other prominent respiratory illnesses. While both influenza and Covid-19 have recorded approximately 50,000 cases each this year, RSV has already exceeded 83,000 confirmed infections, according to the AMA and IFA. Medical professionals expect this trajectory to continue, particularly as students return to school for the new term. UNSW social scientist Professor Holly Seale noted that the return to school may drive a shift in transmission patterns.

The Impact of Aging on Immune Response

While often associated with childhood illness, RSV poses significant risks to older Australians. Gold Logie-winning actress Georgie Parker, 61, has publicly urged older adults to take the virus seriously, noting that she previously underestimated the severity of RSV in adults. “As we age, natural changes in our immune system can make it harder for our bodies to respond to infections like RSV,” Parker stated. Her comments highlight a common misconception that the virus is exclusively a threat to the very young or those with pre-existing vulnerabilities.

Vaccination Strategies for Vulnerable Australians

Public health initiatives are currently focused on closing the immunity gap among older age groups. In May 2026, the free RSV vaccine program was expanded to include all Australians aged 75 and over. This follows the 2025 introduction of a free vaccine for pregnant mothers. IFA founder Catherine Hughes reported that 700,000 vulnerable older Australians received the vaccine within the first two months of the program. Despite this progress, health officials emphasize that coverage remains incomplete.

Preparing Healthcare Systems for a Winter Surge

Hospitals are currently monitoring the situation closely as they prepare for a potential increase in patient volume. AMA president Danielle McMullen stated that while hospitals are not yet under significant pressure, the public needs to act now. “With so many Australians yet to be protected against RSV, it’s essential that people speak to a healthcare professional about RSV protection. Now is the time to act – winter is far from over,” McMullen said. The goal is to replicate the success seen in infant protection programs, which have significantly reduced the need for intensive care and oxygen support among babies.

Frequently Asked Questions

Is the RSV vaccine free for everyone?

The vaccine is free for specific groups, including pregnant mothers and Australians aged 75 and over. Consult your healthcare provider to confirm your eligibility.

How does RSV differ from a common cold?

While RSV symptoms often resemble a cold, the virus has a higher potential to cause dangerous respiratory issues, particularly in infants and the elderly, which can lead to hospitalizations.

Why are cases expected to increase?

Health experts point to the return of students to school and the ongoing winter season as primary factors for the expected surge toward 120,000 cases.

Have you or a family member consulted a GP about RSV protection this winter? Share your experience in the comments below or subscribe to our health newsletter for the latest updates on immunization programs in your area.